In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery

► Synthesis and characterization of novel amphiphilic chitosan derivates as drug delivery system. ► Introduction of phthalyl groups could lower CMC and improve solubility in aqueous and organic system. ► Drug-loaded micelles with small particle size, narrow distribution and high drug loading efficie...

Full description

Saved in:
Bibliographic Details
Published inCarbohydrate polymers Vol. 92; no. 1; pp. 545 - 554
Main Authors Qu, Ding, Lin, Haijiao, Zhang, Nan, Xue, Jingwei, Zhang, Can
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 30.01.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► Synthesis and characterization of novel amphiphilic chitosan derivates as drug delivery system. ► Introduction of phthalyl groups could lower CMC and improve solubility in aqueous and organic system. ► Drug-loaded micelles with small particle size, narrow distribution and high drug loading efficiency. ► Enhancement on cellular uptake by active tumor targeting. ► Mechanism of cellular uptake varied from different surface properties. In this study, a novel amphiphilic copolymer designed as N-octyl-N-phthalyl-3,6-O-(2-hydroxypropyl) chitosan (OPHPC) were synthesized and then conjugated with folic acid (FA-OPHPC) to produce a targeted drug carrier for tumor-specific drug delivery. OPHPC and FA-OPHPC were characterized by FT-IR, 1H NMR, 13C NMR and elemental analysis. Paclitaxel (PTX) loaded OPHPC micelles (PTX-OPHPC) with well-defined spherical shape and homogeneous distribution exhibited drug-loading rate ranging from 33.6% to 45.3% and entrapment efficiency from 50.5% to 82.8%. In the cellular uptake studies, PTX-OPHPC brought about a significantly higher amount of PTX accumulated in human breast adenocarcinoma cell line (MCF-7 cells) compared with Taxol®. Moreover, the cellular uptake of PTX in PTX loaded FA-OPHPC micelles (PTX-FA-OPHPC) was 3.2-fold improved in comparison with that of PTX-OPHPC. The results revealed that OPHPC micelle might be a promising drug carrier for promoting PTX cellular uptake and FA-OPHPC micelle could be used as a potential tumor-targeted drug vector.
Bibliography:http://dx.doi.org/10.1016/j.carbpol.2012.08.112
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0144-8617
1879-1344
1879-1344
DOI:10.1016/j.carbpol.2012.08.112